# Boston Scientific to acquire Apollo Endosurgery for $615M

Boston Scientific has agreed to acquire Apollo Endosurgery for $10 per share, an enterprise value of approximately $615 million, to expand its endoluminal surgery portfolio.

- Type: Acquisition
- Announced: 2022-11-29
- Where: Marlborough, Massachusetts, United States
- Value: $615.0M
- Status: announced
- Products: endoluminal surgery devices, endobariatric devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Apollo Endosurgery](https://endata.com/companies/66916.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2022-11-29-Boston-Scientific-Announces-Agreement-to-Acquire-Apollo-Endosurgery,-Inc), 2022-11-29: "Boston Scientific today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.